3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Retinoblastoma
1
Retinal Neoplasms
1
Hemangioma
1
Interventions
Carboplatin
26
Etoposide
22
Vincristine
18
Melphalan
14
Filgrastim
14
Topotecan
11
Granulocyte Colony-Stimulating Factor
10
Cyclophosphamide
9
Thiotepa
7
Cryotherapy
6
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Drug Therapy
4
Busulfan
4
Radiotherapy
3
Ifosfamide
3
Doxorubicin
3
Temozolomide
2
Platinum Compounds
2
Eye Enucleation
2
Cisplatin
2
Brachytherapy
2
trioctyl phosphine oxide
1
sargramostim
1
racotumomab
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
etoposide phosphate
1
cixutumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Retinoblastoma
×
Lasers, Semiconductor
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled